SLNO — SOLENO THERAPEUTICS INC
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1484565 ·
Last close
$53.01
Market Cap
$2.76B
52W High
$53.01
52W Low
$29.43
ADV30
3,349,453
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 94,603,000 | 93,405,000 | 31,762,000 | 31,378,000 | 608,388,000 | 133,026,000 | 112,588,000 |
| Dec 2025 | 91,730,000 | 90,867,000 | 40,431,000 | 43,358,000 | 563,830,000 | 70,106,000 | 113,715,000 |
| Sep 2025 | 66,018,000 | 64,877,000 | 22,719,000 | 26,013,000 | 599,895,000 | 246,662,000 | 105,090,000 |
| Jun 2025 | 32,657,000 | 31,961,000 | -5,424,000 | -4,708,000 | 332,306,000 | 76,497,000 | 92,166,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$46,798,000
Investing CF
$-201,781,000
Financing CF
$137,161,000
CapEx
$-73,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.23
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-431,370,000
Inventory
$15,024,000
Receivables
$28,208,000
ST Investments
$235,366,000
EBIT TTM
$26,366,000
Pretax Income TTM
$20,890,000
Interest Exp TTM
$5,476,000
Analysts
8
Yahoo Snapshot (yfinance, live)
Total Revenue
$285,008,000
EBITDA
$91,515,000
Free Cash Flow
$91,667,624
Enterprise Value
$2,561,566,976
Total Cash
$255,599,008
Total Debt
$54,277,000
Shares Out
52,120,147
Trailing EPS
$1.93
Book Value
$8.61
ROE
26.4%
ROA
12.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 190,405,000 | 14,950,000 | 20,890,000 | 563,830,000 | 113,715,000 | — | 46,798,000 |
| Dec 2024 | 0 | -184,429,000 | -175,850,000 | 330,972,000 | 85,859,000 | — | -69,096,000 |
| Dec 2023 | 0 | -38,670,000 | -38,988,000 | 180,691,000 | 23,184,000 | — | -24,940,000 |
| Dec 2022 | 0 | -25,109,000 | -24,067,000 | 26,497,000 | 16,149,000 | — | -20,781,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-2.27
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ALMS | ALUMIS INC. | $2.76B | $22.33 | — |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | $2.77B | $47.77 | — |
| KLRA | Kailera Therapeutics, Inc. | $2.79B | $21.57 | — |
| GPCR | Structure Therapeutics Inc. | $2.81B | $39.58 | — |
| ARQT | Arcutis Biotherapeutics, Inc. | $2.64B | $21.11 | — |
News headlines (Yahoo Finance, 1h cache)
Neurocrine Biosciences Completes Acquisition of Soleno Therapeutics
2026-05-18 12:46 · Yahoo
Soleno Merger With Neurocrine Puts Profitability And Valuation In Focus
2026-05-11 03:14 · Yahoo
Neurocrine Biosciences Q1 Earnings Call Highlights
2026-05-06 01:35 · Yahoo
Neurocrine Biosciences Reports First-Quarter 2026 Financial Results
2026-05-05 20:01 · Yahoo
Soleno Therapeutics (SLNO) Surges Nearly 60% In April Amid Neurocrine Acquisition Deal
2026-05-01 14:46 · Yahoo
Folia Health Launches “BRAVE-PWS” Study to Better Understand the Real-World Experience of Prader-Willi Syndrome Caregivers
2026-04-15 12:00 · Yahoo
Soleno Therapeutics Stock Rallies 56.4% in a Week: Here's Why
2026-04-08 15:23 · Yahoo
Neurocrine Soleno Deal Adds Vykat XR And Alters Valuation Story
2026-04-07 14:08 · Yahoo
Arm downgraded, Arista Networks upgraded: Wall Street's top analyst calls
2026-04-07 13:47 · Yahoo
Company News for Apr 7, 2026
2026-04-07 13:33 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.